Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Extramural Vascular Invasion Positive(EMVI+) is a high risk of distant metastasis for locally
advanced rectal cancer(LARC) after resection. The study is to evaluate the efficacy and
safety of mFOLFOXIRI as neoadjuvant chemotherapy alone for EMVI+ LARC.